Your browser doesn't support javascript.
loading
Cervical cancer screening programs in Latin America: current recommendations for facing elimination challenges.
Fernández-Deaza, Ginna; Caicedo-Martínez, Maria; Serrano, Beatriz; Roura, Esther; Castillo, Juan Sebastián; De Sanjosé, Silvia; Bruni, Laia; Murillo, Raúl.
Afiliação
  • Fernández-Deaza G; Centro Javeriano de Oncología, Hospital Universitario San Ignacio. Bogota, Colombia. fernandez.ginna@javeriana.edu.co.
  • Caicedo-Martínez M; Centro Javeriano de Oncología, Hospital Universitario San Ignacio. Bogota, Colombia. mcaicedo@husi.org.co.
  • Serrano B; Cancer Epidemiology Research Program, Institut Català d'Oncologia, IDIBELL, L'Hospitalet de Llobregat. Barcelona, Spain. bscarro@iconcologia.net.
  • Roura E; Centro de Investigación Biomédica en Red, Epidemiología y Salud Pública. Madrid, Spain. eroura@iconcologia.net.
  • Castillo JS; Facultad de Medicina, Pontificia Universidad Javeriana. Bogota, Colombia. juan_castillo@javeriana.edu.co.
  • De Sanjosé S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health. USA. silvia.desanjose@nih.gov.
  • Bruni L; Cancer Epidemiology Research Program, Institut Català d'Oncologia, IDIBELL, L'Hospitalet de Llobregat. Barcelona, Spain. lbruni@iconcologia.net.
  • Murillo R; Centro Javeriano de Oncología, Hospital Universitario San Ignacio. Bogota, Colombia/Early Detection, Prevention & Infection Branch, International Agency for Research on Cancer. Lyon, France. rmurillo@husi.org.co.
Salud Publica Mex ; 64(4, jul-ago): 415-423, 2022 Jul 08.
Article em En | MEDLINE | ID: mdl-36130384
ABSTRACT

OBJECTIVE:

To describe current cervical cancer screening program guidelines in Latin America. MATERIALS AND

METHODS:

We searched official recommendations for the general population and women living with HIV (WLHIV) by reviewing official sources from 19 countries; these data were supplemented with a consultation carried out by the WHO with the Ministries of Health.

RESULTS:

Screening policies vary significantly in regard to target populations, primary tests, and screening intervals. Sixteen countries have recently updated their recommendations; however, cytology remains the primary screening test for most countries. Eleven countries have introduced HPV tests, and eight countries have implemented screen-and-treat algorithms; only three countries have developed evidence-based guidelines. All countries but Costa Rica have specific recommendations for WLHIV.

CONCLUSIONS:

Although most countries have updated their screening policies, only a few are properly alig-ned with the WHO elimination strategy. Recommendations for WLHIV require better integration with cervical cancer screening programs.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus Idioma: En Ano de publicação: 2022 Tipo de documento: Article